|
1
|
Smith RA, Andrews KS, Brooks D, Fedewa SA,
Manassaram-Baptiste D, Saslow D, Brawley OW and Wender RC: Cancer
screening in the United States, 2017: A review of current American
Cancer Society guidelines and current issues in cancer screening.
CA Cancer J Clin. 67:100–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Knutson KL, Karyampudi L, Lamichhane P and
Preston C: Targeted immune therapy of ovarian cancer. Cancer
Metastasis Rev. 34:53–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Killedar A, Stutz MD, Sobinoff AP,
Tomlinson CG, Bryan TM, Beesley J, Chenevix-Trench G, Reddel RR and
Pickett HA: A common cancer risk-associated allele in the hTERT
locus encodes a dominant negative inhibitor of telomerase. PLoS
Genet. 11:e10052862015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan C, Yang F, Zhou C, Chen X, Han X, Liu
X, Ma H and Zheng W: MCT1 promotes the cisplatin-resistance by
antagonizing Fas in epithelial ovarian cancer. Int J Clin Exp
Pathol. 8:2710–2718. 2015.PubMed/NCBI
|
|
6
|
Vallo S, Michaelis M, Rothweiler F,
Bartsch G, Gust KM, Limbart DM, Rödel F, Wezel F, Haferkamp A and
Cinatl J Jr: Drug-resistant urothelial cancer cell lines display
diverse sensitivity profiles to potential second-line therapeutics.
Transl Oncol. 8:210–216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takano M, Kakizoe S, Kawami M, Nagai J,
Patanasethnont D, Sripanidkulchai B and Yumoto R: Modulation of
P-glycoprotein function and multidrug resistance in cancer cells by
Thai plant extracts. Pharmazie. 69:823–828. 2014.PubMed/NCBI
|
|
8
|
Territo PR, Maluccio M, Riley AA, McCarthy
BP, Fletcher J, Tann M, Saxena R and Skill NJ: Evaluation of
11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2
deficient mouse model of hepatocellular carcinoma. BMC Med Imaging.
15:152015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jing X, Zhang H, Hu J, Su P, Zhang W, Jia
M, Cheng H, Li W and Zhou G: β-arrestin 2 is associated with
multidrug resistance in breast cancer cells through regulating MDR1
gene expression. Int J Clin Exp Pathol. 8:1354–1363.
2015.PubMed/NCBI
|
|
10
|
Sun Y, Liu JH, Jin L, Sui YX, Han LL and
Huang Y: Effect of autophagy-related beclin1 on sensitivity of
cisplatin-resistant ovarian cancer cells to chemotherapeutic
agents. Asian Pac J Cancer Prev. 16:2785–2791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Y, Liu JH, Jin L, Sui YX, Lai L and
Yang Y: Inhibition of Beclin 1 expression enhances
cisplatin-induced apoptosis through a mitochondrial-dependent
pathway in human ovarian cancer SKOV3/DDP cells. Oncol Res.
21:261–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song JM, Hu X, Fu X, Liu K and Li GM:
Effects of circadian genes hClock and hBmal1 on migration and
invasion of SGC-7901 cells. Xiandai Zhongliu Yixue. 21:2678–2681.
2013.
|
|
13
|
Hu ML, Yeh KT, Lin PM, Hsu CM, Hsiao HH,
Liu YC, Lin HY, Lin SF and Yang MY: Deregulated expression of
circadian clock genes in gastric cancer. BMC Gastroenterol.
14:672014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Filipski E, Subramanian P, Carrière J,
Guettier C, Barbason H and Lévi F: Circadian disruption accelerates
liver carcinogenesis in mice. Mutat Res. 680:95–105. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang L, Yang Z, Zhou J, Tung JY, Hsiao CD,
Wang L, Deng Y, Wang P, Wang J and Lee MH: Circadian clock gene
cry2 degradation is involved in chemoresistance of colorectal
cancer. Mol Cancer Ther. 14:1476–1487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan-Hong H, Jing L, Hong L, Shan-Shan H,
Yan L and Ju L: Association between alcohol consumption and the
risk of ovarian cancer: A meta-analysis of prospective
observational studies. BMC Public Health. 15:2232015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui X, Li L, Yan G, Meng K, Lin Z, Nan Y,
Jin G and Li C: High expression of NQO1 is associated with poor
prognosis in serous ovarian carcinoma. BMC Cancer. 15:2442015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao L, Ye X, Ma RQ, Cheng HY, Han HJ, Cui
H, Wei LH and Chang XH: Low programmed cell death 5 expression is a
prognostic factor in ovarian cancer. Chin Med J (Engl).
128:1084–1090. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lambrechts S, Lambrechts D, Despierre E,
Van Nieuwenhuysen E, Smeets D, Debruyne PR, Renard V, Vroman P,
Luyten D, Neven P, et al: Genetic variability in drug transport,
metabolism or DNA repair affecting toxicity of chemotherapy in
ovarian cancer. BMC Pharmacol Toxicol. 16:22015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rooth C: Ovarian cancer: Risk factors,
treatment and management. Br J Nurs. 22:S23–S30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Q, Burdette JE and Wang JP:
Integrative network analysis of TCGA data for ovarian cancer. BMC
Syst Biol. 8:13382014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Longoria TC and Eskander RN: Immune
checkpoint inhibition: Therapeutic implications in epithelial
ovarian cancer. Recent Pat Anticancer Drug Discov. 10:133–144.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jung H, Choe Y, Kim H, Park N, Son GH,
Khang I and Kim K: Involvement of CLOCK: BMAL1 heterodimer in
serum-responsive mPer1 induction. Neuroreport. 14:15–19. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bjarnason GA, Jordan RC and Sothern RB:
Circadian variation in the expression of cell-cycle proteins in
human oral epithelium. Am J Pathol. 154:613–622. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Uth K and Sleigh R: Deregulation of the
circadian clock constitutes a significant factor in tumorigenesis:
A clockwork cancer. Part II. In vivo studies. Biotechnol Biotechnol
Equip. 28:379–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tavano F, Pazienza V, Fontana A, Burbaci
FP, Panebianco C, Saracino C, Lombardi L, De Bonis A, di Mola FF,
di Sebastiano P, et al: SIRT1 and circadian gene expression in
pancreatic ductal adenocarcinoma: Effect of starvation. Chronobiol
Int. 32:497–512. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang F, Li C, Yongluo and Chen L: The
circadian gene clock plays an important role in cell apoptosis and
the DNA damage response in vitro. Technol Cancer Res Treat.
15:480–486. 2016. View Article : Google Scholar : PubMed/NCBI
|
